Advertisement

More articles from Cancer Therapy: Clinical

  • DARA-Dependent, Effector Cell–Mediated CD38 Reduction
    Jakub Krejcik, Kris A. Frerichs, Inger S. Nijhof, Berris van Kessel, Jeroen F. van Velzen, Andries C. Bloem, Marloes E.C. Broekmans, Sonja Zweegman, Johan van Meerloo, René J.P. Musters, Pino J. Poddighe, Richard W.J. Groen, Christopher Chiu, Torben Plesner, Henk M. Lokhorst, A. Kate Sasser, Tuna Mutis, Niels W.C.J. van de Donk
    Clinical Cancer Research Dec 2017, 23 (24) 7498-7511; DOI: 10.1158/1078-0432.CCR-17-2027
  • Phase I Study of Ipafricept (OMP-54F28) in Solid Tumors
    Antonio Jimeno, Michael Gordon, Rashmi Chugh, Wells Messersmith, David Mendelson, Jakob Dupont, Robert Stagg, Ann M. Kapoun, Lu Xu, Shailaja Uttamsingh, Rainer K. Brachmann, David C. Smith
    Clinical Cancer Research Dec 2017, 23 (24) 7490-7497; DOI: 10.1158/1078-0432.CCR-17-2157
  • PBPK Modeling of AZD1775 Penetration into Brain Tumors
    Jing Li, Jianmei Wu, Xun Bao, Norissa Honea, Youming Xie, Seongho Kim, Alex Sparreboom, Nader Sanai
    Clinical Cancer Research Dec 2017, 23 (24) 7454-7466; DOI: 10.1158/1078-0432.CCR-17-0983
  • ASP8273 for EGFRmut+ NSCLC Patients with Prior TKI Treatment
    Helena A. Yu, Alexander Spira, Leora Horn, Jared Weiss, Howard West, Giuseppe Giaccone, Tracey Evans, Ronan J. Kelly, Bhardwaj Desai, Andrew Krivoshik, Diarmuid Moran, Srinivasu Poondru, Fei Jie, Kouji Aoyama, Anne Keating, Geoffrey R. Oxnard
    Clinical Cancer Research Dec 2017, 23 (24) 7467-7473; DOI: 10.1158/1078-0432.CCR-17-1447
  • Adjuvant Galinpepimut-S in Malignant Pleural Mesothelioma
    Marjorie G. Zauderer, Anne S. Tsao, Tao Dao, Katherine Panageas, W. Victoria Lai, Andreas Rimner, Valerie W. Rusch, Prasad S. Adusumilli, Michelle S. Ginsberg, Daniel Gomez, David Rice, Reza Mehran, David A. Scheinberg, Lee M. Krug
    Clinical Cancer Research Dec 2017, 23 (24) 7483-7489; DOI: 10.1158/1078-0432.CCR-17-2169
  • Ipilimumab Induced T-Cell Activation in NSCLC
    John S. Yi, Neal Ready, Patrick Healy, Chelsae Dumbauld, Robyn Osborne, Mark Berry, Debra Shoemaker, Jeffrey Clarke, Jeffrey Crawford, Betty Tong, David Harpole, Thomas A. D'Amico, Frances McSherry, Frank Dunphy, Shannon J. McCall, Jared D. Christensen, Xiaofei Wang, Kent J. Weinhold
    Clinical Cancer Research Dec 2017, 23 (24) 7474-7482; DOI: 10.1158/1078-0432.CCR-17-2005
  • Use of TDM for Carboplatin Dosing in High-Dose Regimen
    Sotheara Moeung, Christine Chevreau, Sophie Broutin, Jérôme Guitton, Bénédicte Lelièvre, Joseph Ciccolini, Christophe Massart, Aude Fléchon, Rémy Delva, Gwenaëlle Gravis, Jean-Pierre Lotz, Jacques-Olivier Bay, Marine Gross-Goupil, Angelo Paci, Sabrina Marsili, Laurence Malard, Etienne Chatelut, Fabienne Thomas
    Clinical Cancer Research Dec 2017, 23 (23) 7171-7179; DOI: 10.1158/1078-0432.CCR-17-1344
  • Radotinib versus Imatinib in Newly Diagnosed CML (RERISE)
    Jae-Yong Kwak, Sung-Hyun Kim, Suk Joong Oh, Dae Young Zang, Hawk Kim, Jeong-A Kim, Young Rok Do, Hyeoung Joon Kim, Joon Seong Park, Chul Won Choi, Won Sik Lee, Yeung-Chul Mun, Jee Hyun Kong, Joo Seop Chung, Ho-Jin Shin, Dae-Young Kim, Jinny Park, Chul Won Jung, Udomsak Bunworasate, Narcisa Sonia Comia, Saengsuree Jootar, Arry Harryanto Reksodiputro, Priscilla B. Caguioa, Sung-Eun Lee, Dong-Wook Kim
    Clinical Cancer Research Dec 2017, 23 (23) 7180-7188; DOI: 10.1158/1078-0432.CCR-17-0957
  • High BCR–ABL at Diagnosis Induces Poor Imatinib Responses
    Paolo Vigneri, Fabio Stagno, Stefania Stella, Alessandra Cupri, Stefano Forte, Michele Massimino, Agostino Antolino, Sergio Siragusa, Donato Mannina, Stefana Stella Impera, Caterina Musolino, Alessandra Malato, Giuseppe Mineo, Carmela Tomaselli, Pamela Murgano, Maurizio Musso, Fortunato Morabito, Stefano Molica, Bruno Martino, Livia Manzella, Martin C. Müller, Andreas Hochhaus, Francesco Di Raimondo
    Clinical Cancer Research Dec 2017, 23 (23) 7189-7198; DOI: 10.1158/1078-0432.CCR-17-0962
  • Entinostat and High-Dose IL2 in Renal Cell Carcinoma
    Roberto Pili, David I. Quinn, Hans J. Hammers, Paul Monk, Saby George, Tanya B. Dorff, Thomas Olencki, Li Shen, Ashley Orillion, Dominick Lamonica, Roberto S. Fragomeni, Zsolt Szabo, Alan Hutson, Adrienne Groman, Susan M. Perkins, Richard Piekarz, Michael A. Carducci
    Clinical Cancer Research Dec 2017, 23 (23) 7199-7208; DOI: 10.1158/1078-0432.CCR-17-1178

Pages